HALO logo
halo search icon
Crescent Biopharma, Inc.
Crescent Biopharma, Inc.
CBIO · NAS

Crescent Biopharma, Inc.

US$18.91

Price Arrow0.43 (2.33%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO GrowthHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Crescent Biopharma, Inc. Overview

CBIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CBIO

icon

Telephone

1.617.430.5595

icon

Address

300 Fifth Avenue, Waltham, MA 02451

Description

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

CBIO Price Chart

Key Stats

Market Cap

US$509.53M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 8.72 - 27.5

Trade Value (12mth)

US$586,656.00

1 week

-7.46%

1 month

-24.79%

YTD

66.79%

1 year

-25.54%

All time high

2605.00

Key Fundamentals

EPS 3 yr Growth

-83.40%

EBITDA Margin

NaN%

Operating Cashflow

-$72m

Free Cash Flow Return

-68.30%

ROIC

-146.90%

Interest Coverage

-69.80

Quick Ratio

6.60

Other Data

Shares Outstanding (Fully Diluted)

30m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CBIO Announcements

Latest Announcements

DateAnnouncements
30 April 26
30 April 26
30 April 26
30 April 26
30 April 26

CBIO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-58.25-23.28-14.78locklocklock
EPS (Fully Diluted)
$locklocklocklock-58.25-23.28-14.78locklocklock
Growth
%locklocklocklock34.56036.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Crescent Biopharma, Inc. (CBIO:NAS)?
Halo FAQ
The current share price of Crescent Biopharma, Inc. (CBIO:NAS) is USD$18.91.
What is the 52-week high share price for Crescent Biopharma, Inc. (CBIO:NAS)?
Halo FAQ
The 52-week high share price for Crescent Biopharma, Inc. (CBIO:NAS) is USD$27.50.
What is the 52-week low share price for Crescent Biopharma, Inc. (CBIO:NAS)?
Halo FAQ
The 52-week low share price for Crescent Biopharma, Inc. (CBIO:NAS) is USD$8.72.
What is the dividend yield for Crescent Biopharma, Inc. (CBIO:NAS)?
Halo FAQ
Crescent Biopharma, Inc. (CBIO:NAS) does not pay a dividend.
What was Crescent Biopharma, Inc. (CBIO:NAS) last dividend payment?
Halo FAQ
Crescent Biopharma, Inc. (CBIO:NAS) does not pay a dividend.
What is the franking level for Crescent Biopharma, Inc. (CBIO:NAS)?
Halo FAQ
Crescent Biopharma, Inc. (CBIO:NAS) has a franking level of 0.00%.
In which sector is Crescent Biopharma, Inc. (CBIO:NAS) classified?
Halo FAQ
Crescent Biopharma, Inc. (CBIO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.